Vor Biopharma (VOR) Other Accumulated Expenses (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Other Accumulated Expenses data on file, last reported at $188000.0 in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 327.27% year-over-year to $188000.0 in Q1 2026; TTM through Mar 2026 was $188000.0, a 327.27% increase from a year earlier, with the FY2025 full-year figure at $554000.0, down 36.47% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $188000.0, down from $554000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for VOR reached as high as $2.4 million in Q3 2023 and fell as low as $35000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $410941.2 across 5 years, with a median of $219000.0 in 2024.
• Across the five-year window, Other Accumulated Expenses tumbled 91.21% in 2023 and jumped 1644.0% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $569000.0 in 2022, then tumbled by 91.21% to $50000.0 in 2023, then soared by 1644.0% to $872000.0 in 2024, then sank by 36.47% to $554000.0 in 2025, then slumped by 66.06% to $188000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $188000.0 in Q1 2026, $554000.0 in Q4 2025, and $35000.0 in Q3 2025.